Aisling Capital
aislingcapital.com
Actively hiring
Biotechnology
Venture Capital
Private Equity
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Portfolio
Companies
118
24 of them startups
Hiring now
15
companies with open roles
Rounds in 12 months
1
$50M raised
Its companies, the freshest money firstAll in Startups
Treeline BiosciencesVenture round $200.1M · 13 mo ago · 10 roles
EarlensVenture round $8M · 19 mo ago
One moment, please...Venture round $16.1M · 21 mo ago
One moment, please...Venture round $62.5M · 4 yr ago
Antios TherapeuticsVenture round $75M · 4 yr ago
Merck.comVenture round $486 · 5 yr ago
Forge BiologicsSeries B $120M · 5 yr ago · 14 roles
Biomea FusionVenture round $56M · 5 yr ago
Jazz Pharmaceuticals Iberia S.L.Venture round $34.9M · 7 yr ago
NUVATION BIOVenture round $275.3M · 7 yr ago
CatalentVenture round $650M · 7 yr ago
Agile Therapeutics ®Venture round $7.8M · 7 yr ago
Ajax HealthVenture round $125M · 8 yr ago
Asensus SurgicalConvertible Note $950k · 9 yr ago
Merck & Co.790 roles
Gilead Sciences334 roles
Galderma256 roles
Reckitt132 roles
Compass Pathways113 roles
Bausch Health51 roles
Ascendis Pharma23 roles
Paratek Pharmaceuticals22 roles
Scholar Rock20 roles
Syndax16 roles
Overview
Aisling Capital is a private investment firm focused on the healthcare and life sciences sector. It invests in biotechnology, specialty pharmaceutical, medical device and healthcare companies, providing growth capital to both private and publicly traded businesses. The firm traces its roots to 2000, when its team began managing a biopharmaceutical fund originally linked to Perseus and Soros, and it is based in New York City.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York
United States
HQ
489 5th Avenue 10th Floor New York, NY 10017
200-500 est. staff
489 5th Avenue, 10th Floor, New York, 10017